Speaker:

Nikolai Wajda, MD

Kaiser GSAA

All speaker(s) above and planner(s) (Dr. Nikolai Wajda) have no relevant financial relationship(s) with ineligible companies to disclose.

Educational Objectives:

At the conclusion of this program, clinicians will be better able to:

- Consistently evaluate the most common causes of ILD in each patient. Screen carefully for obscure causes
- Understand how radiographic and pathologic patterns of disease impact prognosis and treatment decisions across a broad array of ILDs.
- Consider MDC review on most or all new diagnoses.
- Evaluate risks/ benefits of immunosuppressive and anti-fibrotic therapy